Ledipasvir and sofosbuvir and Tenofovir interaction

Ledipasvir and sofosbuvir and Tenofovir: both prescribing labels flag this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.

Major

Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.

What the FDA labels say

From the Ledipasvir and sofosbuvir label · effective 2025-01-10

Major

Consider alternative HCV or antiretroviral therapy to avoid increases in tenofovir exposures.

Drug interactionsby drug classView label on DailyMed
Moderate

Concomitant Drug Class: Drug Name Effect on Concentration ↓ = decrease, ↑ = increase Clinical Comment tenofovir DF = tenofovir disoproxil fumarate Acid Reducing Agents: ↓ ledipasvir Ledipasvir solubility decreases as pH increases.

Drug interactionsnames TenofovirView label on DailyMed
Moderate

Refer to Viread ® or Truvada ® prescribing information for recommendations on renal monitoring.

Drug interactionsnames TenofovirView label on DailyMed
Moderate

Regimens containing tenofovir DF and an HIV protease inhibitor/ritonavir or cobicistat atazanavir/ritonavir or cobicistat + emtricitabine/tenofovir DF darunavir/ritonavir or cobicistat + emtricitabine/tenofovir DF lopinavir/ritonavir + emtricitabine/tenofovir DF ↑ tenofovir The safety of increased tenofovir concentrations in the setting of ledipasvir and sofosbuvir…

Drug interactionsnames TenofovirView label on DailyMed
Moderate

If coadministration is necessary, monitor for tenofovir-associated adverse reactions.

Drug interactionsnames TenofovirView label on DailyMed

From the Tenofovir (Viread) label · effective 2025-02-18

Moderate

…sofosbuvir/velpatasvir/voxilaprevir ↑ tenofovir Monitor patients receiving VIREAD concomitantly with EPCLUSA ® (sofosbuvir/velpatasvir) for adverse reactions associated with TDF. ledipasvir/sofosbuvir Monitor patients receiving VIREAD concomitantly with HARVONI ® (ledipasvir/sofosbuvir) without an HIV-1 protease inhibitor/ritonavir or an HIV-1 protease inhibitor/cobicistat…

Drug interactionsnames Ledipasvir and sofosbuvirView label on DailyMed
Moderate

In patients receiving VIREAD concomitantly with HARVONI and an HIV-1 protease inhibitor/ritonavir or an HIV-1 protease inhibitor/cobicistat combination, consider an alternative HCV or antiretroviral therapy, as the safety of increased tenofovir concentrations in this setting has not been established.

Drug interactionsnames Ledipasvir and sofosbuvirView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.